Pepric

Foundation date

14/04/2009

Sector

#Supplier & Engineering

Subsector

Therapeutic areas

Pepric provides pEPR (particle Electron Paramagnetic Resonance) instruments for in-vitro quantification of superparamagnetic nanoparticles in samples. Fast and accurate measurements by Pepric's robotized particle spectrometer are used for the preclinical tests of hyperthermia or (stem) cell therapies in oncology, cardiology, dermatology, and etc, and in vaccine developments by tracking the pharmacokinetics of therapeutic particles, (stem) cells, medicines or vaccine carriers that utilize super paramagnetic iron oxide nano particles (SPION) or magnetic nano particles (MNP).

Upcoming events

Latest news

  • Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States

    Thursday November 30th 2023

  • Agomab appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer

    Wednesday November 29th 2023

  • Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure

    Wednesday November 29th 2023